Immunovant, Inc. (IMVT)
26.66
-0.06
(-0.22%)
USD |
NASDAQ |
Mar 06, 16:00
26.65
-0.01
(-0.04%)
After-Hours: 20:00
Immunovant SG&A Expense (TTM) : 79.15M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Boston Scientific Corp. | 6.888B |
| Viridian Therapeutics, Inc. | 95.31M |
| Plus Therapeutics, Inc. | 11.09M |
| Nutriband, Inc. | 7.831M |
| Definium Therapeutics, Inc. | 48.64M |